Exosens Stock Rebounds by 3.5%
The Bordeaux-based optronic company recovers ground on Monday, in an almost stable SBF 120, posting one of the index's best daily performances. The rebound comes after several weeks of pressure on the security, which had lagged behind its early summer levels.
A Rebound Supported by Nearby Resistance as Moving Averages Cap the Stock
Exosens gains 3.26% to €57.00 during the session, while the SBF 120 advances by only 0.09%. The stock remains however below its three moving averages: the 200-day MA at €58.24 stands 2.13% above the price, the 50-day MA at €59.67 shows a gap of 4.47%, and the 20-day MA at €61.52 widens the gap further (-7.35%). This configuration reflects medium-term dynamics still oriented downward, even though today's rebound partially offsets the monthly decline of 10.24%.
The price nevertheless evolves just above the support level at €56.45, a level tested closely during recent sessions. The RSI at 39, approaching oversold territory without plunging into it, signals exhaustion of selling pressure without confirmation of a reversal.
Exosens Anchored in Optronic Defense, with Confirmed U.S. Commercial Momentum
Fundamentally, Exosens recorded a notable commercial milestone in the United States at end of August: the U.S. Army's first order on the BiNOD binocular night vision program, obtained through its Photonis Defense subsidiary as part of an IDIQ master contract announced in March 2026. Prior to this order, the company published solid first-half results on July 28, 2026, with growth of 15.3% and record adjusted EBITDA margin at 33.0%. Over one year, the stock still shows a gain of 55.53%, reflecting a trajectory driven by the expansion of the optronic defense market, a sector cited among opportunities when first-quarter 2026 results were published (April 27, 2026). The analyst consensus on the stock remains to be monitored to assess whether the decline of recent weeks has altered views on the value.
